Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer

Area of Science:

• Phytochemistry
• Pharmacology
• Drug Discovery

Background:

• Andrographis paniculata (Burm. f) Nees, known as 'king of bitters', is a plant traditionally used in Asian countries for respiratory infections.
• Major labdane diterpenoids like andrographolide are isolated from this plant.

Purpose of the Study:

• To explore the anti-inflammatory and anticancer activities of andrographolide and its synthetic analogues.
• To investigate the mechanisms underlying the therapeutic effects of andrographolide.

Main Methods:

• Synthesis of andrographolide analogues by modifying key chemical structures.
• In vitro and in vivo experimental models to assess anti-inflammatory and anticancer activities.
• Analysis of signaling pathways, including NF-κB, JAK-STAT, and PI3K, involved in the drug's action.

Main Results:

• Andrographolide and its derivatives exhibit significant anti-inflammatory effects in various models.
• Synthetic analogues often show enhanced anticancer activity compared to natural compounds.
• Mechanisms include inhibition of key signaling pathways (NF-κB, JAK-STAT, PI3K) and induction of tumor suppressor proteins.

Conclusions:

• Andrographolide and its derivatives possess potent anti-inflammatory and anticancer properties.
• Drug discovery efforts focused on andrographolide analogues represent a promising strategy for novel therapeutics.
• Further development of andrographolide-based drugs could lead to new treatments for inflammatory diseases and cancer.